Rooted in the Greater Bay Area, Serving the World | Guangzhou Royal Lee Cancer Hospital: Setting a New Benchmark for International Healthcare, Connecting Asia's Health Future

In an era where global medical resources are flowing faster and cross-border cooperation in the health industry is increasingly close, Guangzhou Royal Lee Cancer Hospital is rapidly emerging as a new highland for premium healthcare in the Greater Bay Area and even Asia, distinguished by its exceptional international medical capabilities and profound humanistic service heritage.

Seizing this momentum, Chairman Mr. Li Min unveiled the "Year of Service" initiative at the beginning of the year during a strategic meeting. He emphasized: "Truly world-class international medicine requires not only cutting-edge technology but also heartfelt service that reaches people." This philosophy serves as a guiding light for every solid step Royallee Hospital takes on its internationalization journey.

Core Advantages: Trinity of Technology, Accreditation, and Service – Leading New Medical Standards

Royallee Hospital stands out in the international medical market with the following five key advantages:

1.  Proven International Practice, Deepening Global Collaboration

    We engage in in-depth cooperation with top-tier medical institutions in Thailand, Indonesia, Singapore, and other countries, actively promoting Chinese medical technology and management models on the world stage.

    △ Vice President Ma Lanying visited the Indonesian National Police Headquarters, laying the foundation for future collaboration on social welfare medical projects.

    △ A delegation from Enterprise Singapore visited the hospital for inspection.

    △ Our medical expert team was exclusively interviewed by Indonesia's Metro TV.

2.  International Accreditation, Ensuring Medical Quality

    The hospital has achieved JCI (Joint Commission International) accreditation and holds GCP (Good Clinical Practice) qualifications, ensuring our medical services adhere to the highest international standards.

3.  Leading Technology Platform: Advancing Minimally Invasive and Proton Therapies

    Our expertise in minimally invasive interventions, such as Y-90 resin microsphere selective internal radiation therapy, is at the forefront internationally. We have also jointly established a Proton Radiotherapy Center with Taihe Cancer Hospital, offering comprehensive and precise treatment options for cancer patients.

    △ Proton Radiotherapy Center

    △ Y-90 Resin Microsphere Selective Internal Radiation Therapy

4.  Multinational Group Background, Deep Roots in Southeast Asia

    As part of the Royal Lee Group, we leverage its extensive medical network and resource accumulation in Southeast Asia, possessing robust capabilities for localized operations and international cooperation.

5.  Comprehensive Service System, Leading Patient Satisfaction

    We serve over 1,000 international patients annually and have established direct billing partnerships with more than 40 global insurance companies, ensuring a convenient and reassuring medical experience for our international patients.

Current Actions: Service Enhancement, Expert Recruitment, Humanistic Integration – Building a Warm International Medical Platform

Royallee Hospital consistently remains patient-centered. While continuously expanding its international medical services, it is systematically advancing its capabilities across three key dimensions: service processes, expert teams, and humanistic care, aiming to build a more attractive and competitive international medical destination.

1. Global Expert Recruitment

    The hospital actively implements its "Expert Introduction Plan," focusing on recruiting leading talents with international backgrounds in fields such as minimally invasive oncology interventions and precision medicine. The appointment of Professor Li Dinggang, a member of the Johns Hopkins University Society of Surgeons and Standing Council Member of the International Society of Cryosurgery, as International Chief Medical Advisor is a significant step in accelerating our internationalization and enhancing global service capabilities.

    △ Professor Li Dinggang conducting a specialized oncology training session.

    Li Dinggang

    Professor, Chief Physician

    Member, Johns Hopkins University Society of Surgeons, USA

    Certified International Medical Consultation Expert, Mayo Clinic, USA

    Standing Council Member, International Society of Cryosurgery

    Leading Expert Representative in the field of Cell and Gene Therapy for Oncology

    Honorary President, Macau Anti-Cancer Charity Association, China

    【Areas of Expertise】

    Specializes in designing and administering personalized comprehensive treatment plans for tumors. With over forty years of clinical practice, he has extensive experience in successfully treating solid tumors (lung, breast, gastric, pancreatic, liver, head and neck, etc.).

    【Major Achievements】

    Beyond surgical oncology, chemotherapy, integrated Chinese-Western medicine, Argon-Helix Knife cryotherapy, thermotherapy, and targeted therapy, he is particularly noted for innovatively applying modern biological gene immunotherapy (such as P53 gene therapy) and fostering multidisciplinary team (MDT) collaboration, forming a unique treatment philosophy and practical system. His team has not only treated numerous cancer patients from across China but has also attracted nearly a thousand patients from nearly 40 countries, including the USA, Germany, UK, Sweden, Norway, Spain, Singapore, India, and Pakistan. His department is recognized as having treated the highest number of international cancer patients in China since the nation's founding.

2. Refined Service Enhancement

    We have established a comprehensive service training system covering medical staff, translators, patient service representatives, and logistics, integrating internationalization and humanization into every aspect of the patient journey.

    △ Specialized training on "Standardizing Medical Etiquette and Optimizing Doctor-Patient Communication".

3. Cross-Cultural Humanistic Integration

    The hospital provides international wards and prayer rooms, and offers meals and services that respect the dietary and cultural needs of diverse populations. We regularly host multicultural events such as Christmas and Eid al-Adha celebrations, ensuring patients feel respected and a sense of belonging during their treatment, embodying our commitment to "Integrating medical excellence with humanistic care, where healing and compassion go hand in hand."

    △ Distinctively designed international wards.

△ 2025 Christmas event.

International Achievements: Serving Global Patients, Building a Cross-Border Medical Bridge

Since its inception, Royallee Hospital has been dedicated to providing professional, high-quality medical services, with its international influence continuously growing:

1.  Active Participation in Building International Academic Platforms

    We actively co-organized international conferences like the "9th Asian Congress of Cryosurgery," continuously enhancing China's international presence and collaborative capacity in the field of oncology.

    △ Our hospital co-organized the 9th Asian Congress of Cryosurgery; President Liang Bing delivered an academic report.

2.  Establishing Cross-Border Medical Service Centers

    The hospital has successively founded the International Medical Center and the Indonesia-China Medical Service Center, promoting the "export" of Chinese medical technology and management models and deepening health cooperation with Southeast Asian nations.

3.  Services Covering Nearly 30 Countries and Regions

    As of 2025, the hospital has provided high-quality medical services to patients from nearly 30 countries and regions, including Australia, Singapore, Indonesia, Algeria, Oman, Egypt, Saudi Arabia, Hong Kong SAR, Macau SAR, and Taiwan region (China), establishing itself as a vital medical hub connecting China with countries along the "Belt and Road."

Embracing the Future: A New Benchmark for International Healthcare

Standing at the intersection of the Guangdong-Hong Kong-Macao Greater Bay Area development and the "Healthy China" initiative, Guangzhou Royal Lee Cancer Hospital is more than just a provider of advanced medical technology; it is a connector for cross-cultural health services and an explorer of new models for international medical cooperation.

With medicine as our bridge and humanistic care as our bond, while providing world-class oncology care, we are dedicated to building an international healthcare ecosystem that respects diversity, shares health, and fosters sustainable collaboration.